Rishi Surana

Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma

Shigekazu Murakami, David Shahbazian, Rishi Surana et al. · Oncogene · 2016 · 219 citations · Full text

Life Sciences, Immunology, Oncology +11

Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2

Eric Zhu, S. Annie Gai, Cary F. Opel et al. · Cancer Cell · 2015 · 183 citations · Full text

Life Sciences, Immunology, Oncology +17

Cryptococcal Urease Promotes the Accumulation of Immature Dendritic Cells and a Non-Protective T2 Immune Response within the Lung

John J. Osterholzer, Rishi Surana, Jami E. Milam et al. · American Journal Of Pathology · 2009 · 138 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic Cancer

Harshabad Singh, Rachel B. Keller, Kevin S. Kapner et al. · Clinical Cancer Research · 2023 · 46 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Phase I study of mesenchymal stem cell (MSC)-derived exosomes with KRAS^G12DsiRNA in patients with metastatic pancreatic cancer harboring a KRAS^G12D mutation.

Rishi Surana, Valerie S. LeBleu, Brandon G. Smaglo et al. · Journal of Clinical Oncology · 2022 · 38 citations

Medicine, Molecular Biology, Oncology +17